Tofacitinib synthesis – An asymmetric challenge

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)
749 Downloads (Pure)


Tofacitinib is a Janus activated kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis and active psoriatic arthritis. Its synthesis normally involves long synthetic sequences due to the chirality associated to the piperidine ring. This review is a comprehensive analysis of the different synthetic methods used to prepare this active pharmaceutical ingredient (API), covering the related journal and patent literature.

Original languageEnglish
Pages (from-to)615-624
Number of pages10
JournalEuropean Journal of Organic Chemistry
Issue number4
Publication statusPublished - 2019


  • Asymmetric synthesis
  • Chiral resolution
  • Nitrogen heterocycles
  • Piperidine rings
  • Tofacitinib


Dive into the research topics of 'Tofacitinib synthesis – An asymmetric challenge'. Together they form a unique fingerprint.

Cite this